LISTED medicinal cannabis company Creso Pharma has just announced its expansion into the Chinese market with the inking of new deals. The company announced it has signed a commercial distribution and strategic partnership with Chinese hemp producer Zhejiang Kingdom Creative Co. that will see Kingdom Creative export Creso's animal and human health hemp and cannabis-derived products to the local Chinese market.
Zhejiang Kingdom Creative Co. is a subsidiary of Hong Kong-listed company Kingdom Group whose revenue for the six months ending 30 Jun 2017 was RMB454.8 million or A$90.6 million.
The deal anticipates the potential for collaboration in cosmetics, body care and medicinal cannabis products in China.
Creso said it had opened four offices in China to support the partnership as it gained a foothold in local markets.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Nov 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Nov 17
